Suven Pharmaceutical Q1 net profit jumps 40.04% at Rs 114.05 cr
The company reported standalone net profit of Rs 114.05 crore for the quarter ended June 30, 2022 as compared to Rs 81.44 crore in the same period last year, registering a year-on-year growth of 40.04 per cent. Net revenue of the company rose substantially by 28.43 per cent at Rs 338.80 crore in April-June quarter of this fiscal as against Rs 263.80 crore in the corresponding period last year.
During April-June quarter, operating expenses increased by 23.38 per cent to Rs 184.06 crore from Rs 149.18 crore in year ago period. Other Income grew by 88.58 per cent at Rs 10.90 crore versus (Jun'21 Rs 5.78 crore). Operating Profit surged by 35.00 per cent to Rs 154.74 crore as against Rs 114.62 crore in the year ago period, while Operating Profit Margin (OPM) expanded year-on-year to 5.11 per cent in June quarter. Interest declined by 32.86 per cent y-o-y to Rs 1.43 crore, while Taxation increased by 42.28 per cent at Rs 39.61 crore (Jun'21 Rs 27.84 crore).